Estimations des analystes de Wall Street pour Elutia Inc (ELUT): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 5 |
| Conserver | 0 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 5 |
| Note moyenne (1-5) | 1.00 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.15 | ||
| 2026-08-13 | $-0.17 | $-0.15 | -13.3% |
| 2026-05-14 | $-0.17 | $-0.15 | -13.3% |
| 2026-03-11 | $-0.14 | $-0.14 | +0.0% |
| 2025-11-06 | $-0.01 | $-0.15 | +93.5% |
| 2025-08-14 | $-0.26 | $-0.17 | -52.9% |
| 2025-05-08 | $-0.21 | $-0.20 | -5.0% |
| 2025-03-06 | $-0.26 | $-0.25 | -4.0% |
Ratios de valorisation
| Ratio P/E | 0.60 |
| Prix / Valeur comptable | 2.18 |
| EV / EBITDA | -1.13 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenus | $39.0M | $42.9M | $42.7M | $47.4M | $23.8M | $24.7M | $24.4M | $12.3M |
| Coût des Ventes | $23.1M | $23.1M | $22.1M | $28.4M | $12.2M | $13.7M | $13.7M | $5.7M |
| Marge Brute | $15.9M | $19.8M | $20.6M | $19.0M | $11.6M | $11.1M | $10.7M | $6.6M |
| R&D | $2.5M | $2.4M | $6.0M | $9.3M | $7.7M | $4.4M | $3.8M | $4.2M |
| Frais Généraux | $21.7M | $25.8M | $28.2M | $32.5M | $33.9M | $27.2M | $31.2M | $20.8M |
| Charges Opérationnelles | $24.2M | $28.2M | $34.2M | $42.1M | $46.8M | $41.6M | $46.4M | $25.0M |
| Résultat Opérationnel | -$8.2M | -$8.4M | -$13.6M | -$23.0M | -$35.2M | -$30.5M | -$35.7M | -$18.4M |
| EBITDA | -$2.2M | -$2.7M | -$12.3M | -$15.7M | -$27.3M | -$31.9M | -$45.9M | -$13.5M |
| Charges d'Intérêt | $5.5M | $5.4M | $5.6M | $5.3M | $5.1M | $5.8M | $4.8M | -$387000 |
| Résultat Avant Impôts | -$11.5M | -$11.9M | -$21.8M | -$24.8M | -$36.1M | -$41.2M | -$54.1M | -$15.9M |
| Impôts | $26000 | $30000 | $26000 | $55000 | $34000 | $28000 | $7000 | $13000 |
| Résultat Net | -$11.6M | -$11.9M | -$21.8M | -$24.8M | -$32.9M | -$37.7M | -$53.9M | $53.4M |
| BPA | $-1.08 | $-1.12 | $-2.13 | $-2.38 | $-2.38 | $-2.07 | $-1.86 | $1.29 |
| BPA Dilué | $-1.08 | $-1.12 | $-2.13 | $-2.38 | $-2.38 | $-2.07 | $-1.86 | $0.87 |
| Actions en Circulation (Diluées) | $10.7M | $10.7M | $10.2M | $10.4M | $13.8M | $18.2M | $29.1M | $45.9M |
Prix
| Prix | $0.81 |
| Capitalisation | $36M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ANVS · BCAB · CALC · CELU · LTRN · MAIA · PYPD
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ELUT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions